These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11564089)

  • 1. Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve.
    Pratt G; Rawstron AC; English AE; Johnson RJ; Jack AS; Morgan GJ; Smith GM
    Br J Haematol; 2001 Sep; 114(4):937-43. PubMed ID: 11564089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment.
    Robinson SN; Freedman AS; Neuberg DS; Nadler LM; Mauch PM
    Exp Hematol; 2000 Dec; 28(12):1325-33. PubMed ID: 11146154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.
    Lanza F; Campioni D; Moretti S; Dominici M; Punturieri M; Focarile E; Pauli S; Dabusti M; Tieghi A; Bacilieri M; Scapoli C; De Angeli C; Galluccio L; Castoldi G
    Exp Hematol; 2001 Dec; 29(12):1484-93. PubMed ID: 11750108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
    Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment.
    Hénon PH; Sovalat H; Bourderont D
    J Biol Regul Homeost Agents; 2001; 15(1):62-7. PubMed ID: 11388746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+/CD90+ cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation.
    Sumikuma T; Shimazaki C; Inaba T; Ochiai N; Okano A; Hatsuse M; Ashihara E; Nakagawa M
    Br J Haematol; 2002 Apr; 117(1):238-44. PubMed ID: 11918561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primordial role of CD34+ 38- cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation.
    Hénon P; Sovalat H; Becker M; Arkam Y; Ojeda-Uribe M; Raidot JP; Husseini F; Wunder E; Bourderont D; Audhuy B
    Br J Haematol; 1998 Nov; 103(2):568-81. PubMed ID: 9827938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+CD38-HLA-DR- correlate more closely than CD34+CD38- with engraftment post-PBSC transplantation.
    Drake M; Ranaghan EA; Alexander HD; Desai ZR; Morris TC
    Br J Haematol; 1999 Mar; 104(3):643-4. PubMed ID: 10086811
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in cell cycle kinetics of candidate engrafting cells in human bone marrow and mobilized peripheral blood.
    Thornley I; Nayar R; Freedman MH; Stephens D; Crump M; Messner HA; Sutherland DR
    Exp Hematol; 2001 Apr; 29(4):525-33. PubMed ID: 11301193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34+38--and CD34+49d+ subsets during apheresis.
    Bojko P; Scharifi M; Stössel K; Seeber S
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):19-28. PubMed ID: 11862468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Heilmann C; Andersen H; Bock J; Russel CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Eur J Haematol; 1999 Mar; 62(3):174-83. PubMed ID: 10089895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
    Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
    Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.
    Gazitt Y; Reading CC; Hoffman R; Wickrema A; Vesole DH; Jagannath S; Condino J; Lee B; Barlogie B; Tricot G
    Blood; 1995 Jul; 86(1):381-9. PubMed ID: 7540887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood.
    Sovalat H; Racadot E; Ojeda M; Lewandowski H; Chabouté V; Hénon P
    J Hematother Stem Cell Res; 2003 Oct; 12(5):473-89. PubMed ID: 14594504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell adhesion molecules in cord blood hematopoietic progenitors.
    Timeus F; Crescenzio N; Marranca D; Dall'Aglio M; Fazio L; Di Marco M; Saracco P; Ricotti M; Gabutti V
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S61-2. PubMed ID: 9715892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased L-selectin expression in CD34-positive cells from patients with chronic myelocytic leukaemia.
    Kawaishi K; Kimura A; Katoh O; Sasaki A; Oguma N; Ihara A; Satow Y
    Br J Haematol; 1996 May; 93(2):367-74. PubMed ID: 8639430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell enumeration in cord blood vs bone marrow and peripheral blood.
    Bertolini F; Battaglia M; Lanza A; Gibelli N; Palermo B; Pavesi L; Robustelli della Cuna G
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S57. PubMed ID: 9715890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.
    Michallet M; Philip T; Philip I; Godinot H; Sebban C; Salles G; Thiebaut A; Biron P; Lopez F; Mazars P; Roubi N; Leemhuis T; Hanania E; Reading C; Fine G; Atkinson K; Juttner C; Coiffier B; Fière D; Archimbaud E
    Exp Hematol; 2000 Jul; 28(7):858-70. PubMed ID: 10907648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.